loadpatents
Patent applications and USPTO patent grants for Roe; Michael Bryan.The latest application filed is for "dosage forms comprising a plasma kallikrein inhibitor".
Patent | Date |
---|---|
Dosage forms comprising a plasma kallikrein inhibitor Grant 11,234,939 - Collett , et al. February 1, 2 | 2022-02-01 |
Dosage Forms Comprising A Plasma Kallikrein Inhibitor App 20200345647 - COLLETT; John Herman ;   et al. | 2020-11-05 |
Pharmaceutical Compositions App 20200261383 - COOK; Gary ;   et al. | 2020-08-20 |
Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3-methyl-4, 10-dihydro-3H-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamid- e Grant 9,073,928 - Batt , et al. July 7, 2 | 2015-07-07 |
Tosylate Salt Of Cyclopropanecarboxylic Acid 4-(6-chloro-3-methyl-4, 10-dihydro-3h-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamid- E App 20130281439 - Batt; Andrzej Roman ;   et al. | 2013-10-24 |
Vasopressin V.sub.1a antagonists Grant 8,202,858 - Batt , et al. June 19, 2 | 2012-06-19 |
Vasopressin V1a Antagonists App 20120101082 - BATT; ANDRZEJ ROMAN ;   et al. | 2012-04-26 |
Vasopressin V1a Antagonists App 20090029965 - Batt; Andrzej Roman ;   et al. | 2009-01-29 |
Benzamide derivatives as oxytocin agonists and vasopressin antagonists App 20080275026 - Hudson; Peter ;   et al. | 2008-11-06 |
Non-peptide GnRH antagonists App 20080255109 - Roe; Michael Bryan ;   et al. | 2008-10-16 |
Benzamide derivatives as oxytocin agonists and vasopressin antagonists Grant 7,407,949 - Hudson , et al. August 5, 2 | 2008-08-05 |
Non-peptide GnRH antagonists Grant 7,365,065 - Roe , et al. April 29, 2 | 2008-04-29 |
Piperazines as oxytocin agonists App 20070197608 - Hudson; Peter ;   et al. | 2007-08-23 |
Benzamide derivatives as oxytocin agonists and vasopressin antagonists App 20060166971 - Hudson; Peter ;   et al. | 2006-07-27 |
Non-peptide gnrh antagonists App 20050222139 - Roe, Michael Bryan ;   et al. | 2005-10-06 |
Diazacycloalkanes as oxytocin agonists App 20050032777 - Hudson, Peter Jeremy ;   et al. | 2005-02-10 |
Oxytocin agonists App 20040235753 - Pitt, Gray Robert William ;   et al. | 2004-11-25 |
Anthranilic acid derivatives as multi drug resistance modulators Grant 6,218,393 - Ryder , et al. April 17, 2 | 2001-04-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.